Wed, February 15, 2023
Tue, February 14, 2023
Mon, February 13, 2023
Sun, February 12, 2023
Fri, February 10, 2023

Gregory Renza Maintained (SPRB) at Buy with Decreased Target to $8 on, Feb 13th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-feb-13th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $9 to $8 on, Feb 13th, 2023.

Gregory has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gregory


  • Jonathan Wolleben of "JMP Securities" Maintained at Buy and Held Target at $8 on, Sunday, January 8th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022

Publication Contributing Sources